Medicine and Dentistry
Breast Cancer
100%
Overall Survival
73%
Neoplasm
60%
Recurrent Disease
51%
Adjuvant Chemoradiotherapy
41%
Bile Duct Cancer
40%
Prognostic Factor
39%
Extrahepatic Bile Duct
37%
Quadrantectomy
36%
Disease Free Survival
36%
Survival Rate
35%
Retrospective Study
29%
Lymph Node
29%
Adjuvant Radiotherapy
28%
Mastectomy
26%
Distant Metastasis Free Survival
20%
Neoadjuvant Chemotherapy
20%
Breast Radiotherapy
17%
Distant Metastasis
17%
Hazard Ratio
17%
Surgical Margin
16%
Brain Metastasis
16%
Hepatocellular Carcinoma
14%
Local Recurrence Free Survival
14%
Intensity Modulated Radiation Therapy
13%
Lymph Node Metastasis
12%
Recurrence Free Survival
11%
Whole Brain Radiotherapy
11%
Cholangiocarcinoma
10%
Fluorouracil
10%
Pelvis
9%
Systemic Therapy
9%
Adjuvant Chemotherapy
9%
Supraclavicular Lymph Node
8%
Meta-Analysis
8%
Volumetric Modulated Arc Therapy
8%
Propensity Score Matching
8%
Adenocarcinoma
8%
Intraductal Carcinoma
8%
Lymph Node Irradiation
7%
Pancreaticoduodenectomy
7%
Surveillance, Epidemiology, and End Results
7%
Progression Free Survival
7%
Metastatic Carcinoma
7%
Phyllodes Tumor
7%
Squamous Cell Carcinoma
7%
Carcinoembryonic Antigen
7%
Breast Tumor
6%
Gamma Urogastrone
6%
Epidermal Growth Factor Receptor 2
6%
Conservative Treatment
6%
Cervical Cancer
6%
Minimal Residual Disease
6%
Internal Mammary Lymph Node
6%
Recurrence Risk
6%
Axillary Lymph Node
6%
Thoracic Wall
5%
Magnetic Resonance Imaging
5%
Survivin
5%
Tumor Recurrence
5%
Cancer Specific Survival
5%
Retroperitoneal Lymph Node Dissection
5%
Risk Stratification
5%
Arm
5%
Biological Marker
5%
Tumor Infiltrating Lymphocyte
5%
Internal Mammary Node
5%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
52%
Neoplasm
47%
Recurrent Disease
35%
Breast Cancer
35%
Survival Rate
29%
Bile Duct Cancer
22%
Disease Free Survival
20%
Fluorouracil
16%
Distant Metastasis Free Survival
15%
Retrospective Study
14%
Local Recurrence Free Survival
12%
Distant Metastasis
10%
Recurrence Free Survival
10%
Liver Cell Carcinoma
9%
Lymph Node Metastasis
8%
Progression Free Survival
7%
Phyllodes Tumor
7%
Brain Metastasis
7%
Adenocarcinoma
6%
Bile Duct Carcinoma
5%
Squamous Cell Carcinoma
5%